176 related articles for article (PubMed ID: 29991562)
21. Stability of cefazolin sodium in four heparinized and non-heparinized dialysate solutions at 38 degrees C.
Robinson RF; Morosco RS; Smith CV; Mahan JD
Perit Dial Int; 2006; 26(5):593-7. PubMed ID: 16973516
[TBL] [Abstract][Full Text] [Related]
22. Stability of cefotaxime in two peritoneal dialysis solutions.
Paap CM; Nahata MC
Am J Hosp Pharm; 1990 Jan; 47(1):147-50. PubMed ID: 2301423
[TBL] [Abstract][Full Text] [Related]
23. Stability Studies of Antipyocyanic Beta-Lactam Antibiotics Used in Continuous Infusion.
Curti C; Souab HK; Lamy E; Mathias F; Bornet C; Guinard B; Fersing C; Primas N; Albanèse J; Vanelle P
Pharmazie; 2019 Jun; 74(6):357-362. PubMed ID: 31138374
[TBL] [Abstract][Full Text] [Related]
24. Stability of miconazole in peritoneal dialysis fluid.
Holmes SE; Aldous S
Am J Hosp Pharm; 1991 Feb; 48(2):286-90. PubMed ID: 2003502
[TBL] [Abstract][Full Text] [Related]
25. Stability of vancomycin in icodextrin peritoneal dialysis solution.
Nornoo AO; Elwell RJ
Ann Pharmacother; 2006 Nov; 40(11):1950-4. PubMed ID: 17062839
[TBL] [Abstract][Full Text] [Related]
26. Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions.
Bahmany S; Ewoldt TMJ; Abdulla A; Koch BCP
Ther Drug Monit; 2023 Oct; 45(5):606-615. PubMed ID: 37199408
[TBL] [Abstract][Full Text] [Related]
27. Preanalytical Stability of Flucloxacillin, Piperacillin, Tazobactam, Meropenem, Cefalexin, Cefazolin, and Ceftazidime in Therapeutic Drug Monitoring: A Structured Review.
Mortensen JS; Jensen BP; Doogue M
Ther Drug Monit; 2022 Dec; 44(6):709-719. PubMed ID: 35175248
[TBL] [Abstract][Full Text] [Related]
28. Stability of moxifloxacin injection in peritoneal dialysis solution bags (Dianeal PD1 1.36% and Dianeal PD1 3.86%).
Fernández-Varón E; Marín P; Espuny A; Villamayor L; Escudero E; Cárceles C
J Clin Pharm Ther; 2006 Dec; 31(6):641-3. PubMed ID: 17176370
[TBL] [Abstract][Full Text] [Related]
29. Stability of drug additives in peritoneal dialysis solutions in a new container.
Voges M; Faict D; Lechien G; Taminne M
Perit Dial Int; 2004; 24(6):590-5. PubMed ID: 15559489
[TBL] [Abstract][Full Text] [Related]
30. Stability of ciprofloxacin in peritoneal dialysis solution.
Mawhinney WM; Adair CG; Gorman SP; McClurg B
Am J Hosp Pharm; 1992 Dec; 49(12):2956-9. PubMed ID: 1481801
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of intraperitoneal piperacillin/tazobactam in patients on peritoneal dialysis with and without pseudomonas peritonitis.
Zaidenstein R; Weissgarten J; Dishi V; Koren M; Soback S; Gips M; Averbuch Z; Simantov R; Assulin E; Golik A
Perit Dial Int; 2000; 20(2):227-31. PubMed ID: 10809248
[TBL] [Abstract][Full Text] [Related]
32. Stability of tedizolid phosphate-sodium rifampicin and tedizolid phosphate-meropenem admixtures in intravenous infusion bags stored at different temperatures.
Ezquer-Garin C; Ferriols-Lisart R; Martinez-López LM; Sangrador-Pelluz C; Nicolás-Picó J; Alós-Almiñana M
Pharmazie; 2020 May; 75(5):172-176. PubMed ID: 32393422
[TBL] [Abstract][Full Text] [Related]
33. Stability of ciprofloxacin injection in peritoneal dialysis solutions.
Kane MP; Bailie GR; Moon DG; Siu I
Am J Hosp Pharm; 1994 Feb; 51(3):373-7. PubMed ID: 8160691
[TBL] [Abstract][Full Text] [Related]
34. Compatibility of fosfomycin with different commercial peritoneal dialysis solutions.
Kussmann M; Baumann A; Hauer S; Pichler P; Zeitlinger M; Wiesholzer M; Burgmann H; Poeppl W; Reznicek G
Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2237-2242. PubMed ID: 28685187
[TBL] [Abstract][Full Text] [Related]
35. Influence of Different Peritoneal Dialysis Fluids on the In Vitro Activity of Cefepime, Ciprofloxacin, Ertapenem, Meropenem and Tobramycin Against Escherichia Coli.
Kussmann M; Schuster L; Wrenger S; Pichler P; Reznicek G; Burgmann H; Poeppl W; Zeitlinger M; Wiesholzer M
Perit Dial Int; 2016 11-12; 36(6):662-668. PubMed ID: 27680756
[TBL] [Abstract][Full Text] [Related]
36. Stability of cefazolin sodium in peritoneal dialysis solutions.
Nahata MC; Ahalt PA
Am J Hosp Pharm; 1991 Feb; 48(2):291-2. PubMed ID: 2003503
[TBL] [Abstract][Full Text] [Related]
37. Quantification of Cefepime, Meropenem, Piperacillin, and Tazobactam in Human Plasma Using a Sensitive and Robust Liquid Chromatography-Tandem Mass Spectrometry Method, Part 2: Stability Evaluation.
D'Cunha R; Bach T; Young BA; Li P; Nalbant D; Zhang J; Winokur P; An G
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29941653
[TBL] [Abstract][Full Text] [Related]
38. Short-Dwell Cycling Intraperitoneal Cefazolin Plus Ceftazidime in Peritoneal Dialysis Patients.
Peerapornratana S; Chariyavilaskul P; Kanjanabuch T; Praditpornsilpa K; Eiam-Ong S; Katavetin P
Perit Dial Int; 2017; 37(2):218-224. PubMed ID: 27738089
[TBL] [Abstract][Full Text] [Related]
39. Stability of meropenem in intravenous solutions.
Patel PR; Cook SE
Am J Health Syst Pharm; 1997 Feb; 54(4):412-21. PubMed ID: 9043564
[TBL] [Abstract][Full Text] [Related]
40. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
Zhanel GG; Golden AR; Zelenitsky S; Wiebe K; Lawrence CK; Adam HJ; Idowu T; Domalaon R; Schweizer F; Zhanel MA; Lagacé-Wiens PRS; Walkty AJ; Noreddin A; Lynch Iii JP; Karlowsky JA
Drugs; 2019 Feb; 79(3):271-289. PubMed ID: 30712199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
